FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376113384> ?p ?o ?g. }

• W4376113384 endingPage "2048" @default.
• W4376113384 startingPage "2043" @default.
• W4376113384 abstract "Anaphylaxis reactions lie on a spectrum of severity, ranging from relatively mild lower respiratory involvement (depending on the definition of anaphylaxis used) to more severe reactions that are refractory to initial treatment with epinephrine and may rarely cause death. A variety of grading scales exist to characterize severe reactions, but there is a lack of consensus about the optimal approach to define severity. More recently, a new entity called refractory anaphylaxis (RA) has emerged in the literature, characterized by the persistence of anaphylaxis despite initial epinephrine treatment. However, slightly different definitions have been proposed to date. In this Rostrum, we review these definitions as well as data relating to epidemiology, elicitors, risk factors, and management of RA. We propose a need to align the different definitions for RA, to improve epidemiological surveillance, advance our understanding of the pathophysiology of RA, and optimize management strategies to reduce morbidity and mortality." @default.
• W4376113384 created "2023-05-12" @default.
• W4376113384 creator A5003883433 @default.
• W4376113384 creator A5005794046 @default.
• W4376113384 creator A5015552885 @default.
• W4376113384 creator A5027993808 @default.
• W4376113384 creator A5037497962 @default.
• W4376113384 creator A5045041188 @default.
• W4376113384 creator A5048737172 @default.
• W4376113384 creator A5048797041 @default.
• W4376113384 creator A5062573949 @default.
• W4376113384 creator A5074756493 @default.
• W4376113384 creator A5076448184 @default.
• W4376113384 creator A5077511496 @default.
• W4376113384 creator A5088377381 @default.
• W4376113384 creator A5091121121 @default.
• W4376113384 date "2023-07-01" @default.
• W4376113384 modified "2023-09-30" @default.
• W4376113384 title "Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis" @default.
• W4376113384 cites W1575356871 @default.
• W4376113384 cites W1986564388 @default.
• W4376113384 cites W2013482517 @default.
• W4376113384 cites W2022406624 @default.
• W4376113384 cites W2048685088 @default.
• W4376113384 cites W2059469682 @default.
• W4376113384 cites W2092442653 @default.
• W4376113384 cites W2108793950 @default.
• W4376113384 cites W2108903085 @default.
• W4376113384 cites W2140344612 @default.
• W4376113384 cites W2144439776 @default.
• W4376113384 cites W2147701903 @default.
• W4376113384 cites W2148856054 @default.
• W4376113384 cites W2278236619 @default.
• W4376113384 cites W2514755523 @default.
• W4376113384 cites W2756779672 @default.
• W4376113384 cites W2803889082 @default.
• W4376113384 cites W2810441482 @default.
• W4376113384 cites W2905118097 @default.
• W4376113384 cites W2942604538 @default.
• W4376113384 cites W2981204147 @default.
• W4376113384 cites W2984998382 @default.
• W4376113384 cites W3011202605 @default.
• W4376113384 cites W3080913254 @default.
• W4376113384 cites W3090263282 @default.
• W4376113384 cites W3097625054 @default.
• W4376113384 cites W3129809510 @default.
• W4376113384 cites W3155813822 @default.
• W4376113384 cites W3156096159 @default.
• W4376113384 cites W3159075974 @default.
• W4376113384 cites W3183900600 @default.
• W4376113384 cites W3192696519 @default.
• W4376113384 cites W4205948840 @default.
• W4376113384 cites W4224219536 @default.
• W4376113384 cites W4316469589 @default.
• W4376113384 cites W4320716996 @default.
• W4376113384 cites W4322772962 @default.
• W4376113384 cites W4327596996 @default.
• W4376113384 cites W4378628350 @default.
• W4376113384 doi "https://doi.org/10.1016/j.jaip.2023.04.037" @default.
• W4376113384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37172716" @default.
• W4376113384 hasPublicationYear "2023" @default.
• W4376113384 type Work @default.
• W4376113384 citedByCount "0" @default.
• W4376113384 crossrefType "journal-article" @default.
• W4376113384 hasAuthorship W4376113384A5003883433 @default.
• W4376113384 hasAuthorship W4376113384A5005794046 @default.
• W4376113384 hasAuthorship W4376113384A5015552885 @default.
• W4376113384 hasAuthorship W4376113384A5027993808 @default.
• W4376113384 hasAuthorship W4376113384A5037497962 @default.
• W4376113384 hasAuthorship W4376113384A5045041188 @default.
• W4376113384 hasAuthorship W4376113384A5048737172 @default.
• W4376113384 hasAuthorship W4376113384A5048797041 @default.
• W4376113384 hasAuthorship W4376113384A5062573949 @default.
• W4376113384 hasAuthorship W4376113384A5074756493 @default.
• W4376113384 hasAuthorship W4376113384A5076448184 @default.
• W4376113384 hasAuthorship W4376113384A5077511496 @default.
• W4376113384 hasAuthorship W4376113384A5088377381 @default.
• W4376113384 hasAuthorship W4376113384A5091121121 @default.
• W4376113384 hasConcept C107130276 @default.
• W4376113384 hasConcept C121332964 @default.
• W4376113384 hasConcept C126322002 @default.
• W4376113384 hasConcept C142424586 @default.
• W4376113384 hasConcept C177713679 @default.
• W4376113384 hasConcept C203014093 @default.
• W4376113384 hasConcept C207480886 @default.
• W4376113384 hasConcept C2775859304 @default.
• W4376113384 hasConcept C2775933838 @default.
• W4376113384 hasConcept C2779726688 @default.
• W4376113384 hasConcept C2781406822 @default.
• W4376113384 hasConcept C71924100 @default.
• W4376113384 hasConcept C87355193 @default.
• W4376113384 hasConceptScore W4376113384C107130276 @default.
• W4376113384 hasConceptScore W4376113384C121332964 @default.
• W4376113384 hasConceptScore W4376113384C126322002 @default.
• W4376113384 hasConceptScore W4376113384C142424586 @default.
• W4376113384 hasConceptScore W4376113384C177713679 @default.
• W4376113384 hasConceptScore W4376113384C203014093 @default.
• W4376113384 hasConceptScore W4376113384C207480886 @default.

• next